Group 1 - Cencora (COR) has gained approximately 24.4% year-to-date, outperforming the average gain of 2% in the Medical sector [4] - Cencora holds a Zacks Rank of 2 (Buy), indicating a positive outlook based on earnings estimates and revisions [3] - The Zacks Consensus Estimate for Cencora's full-year earnings has increased by 0.1% over the past quarter, reflecting improving analyst sentiment [3] Group 2 - Cencora is part of the Medical Services industry, which consists of 58 stocks and currently ranks 77 in the Zacks Industry Rank [5] - The Medical Services industry has an average gain of 3.9% year-to-date, indicating that Cencora is performing better than its industry peers [5] - Intensity Therapeutics Inc. (INTS), another Medical stock, has also outperformed the sector with a year-to-date return of 13.6% [4][6]
Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?